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Abstract: Highly pathogenic avian influenza (HPAI) viruses of the H5N1 strain pose a 
pandemic threat. H5N1 strain virus is extremely lethal and contagious for poultry. Even 
though mortality is 59% in infected humans,  these viruses do not spread efficiently 
between humans. In 1997, an outbreak of H5N1 strain with human cases occurred in Hong 
Kong. This event highlighted the need for rapid identification and subtyping of influenza A 
viruses (IAV), not only to facilitate surveillance of the pandemic potential of avian IAV, 
but also to improve the control and treatment of infected patients. Molecular diagnosis has 
played a key role in the detection and typing of IAV in recent years, spurred by rapid 
advances in technologies for detection and characterization of viral RNAs and proteins. 
Such  technologies,  which  include  immunochromatography,  quantitative  real-time PCR, 
super high-speed real-time PCR, and  isothermal DNA amplification, are expected to 
contribute to faster and easier diagnosis and typing of IAV. 
Keywords:  influenza virus;  highly pathogenic avian influenza virus H5N1;  molecular 
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1. Influenza Virus 
Influenza  is  a  highly contagious  respiratory disease of  humans,  caused by negative-strand, 
segmented  RNA viruses belonging  to  the family Orthomyxoviridae  [1].  There are three different 
genera of influenza virus; type A, type B, and type C. Seasonal outbreaks, caused by influenza A and 
B viruses,  constitute a  global health issue, leading to  morbidity, mortality, and economic losses. 
Influenza A viruses (IAV) are the cause of pandemics, including “Spanish influenza” (subtype H1N1 
in 1918), “Asian influenza” (subtype H2N2 in 1957), “Hong Kong influenza” (subtype H3N2 in 1968), 
and A/H1N1pdm (subtype H1N1 in 2009). The worst of these pandemics was “Spanish influenza”, 
which was reported to cause 30,000,000–60,000,000 deaths worldwide and 390,000 deaths in Japan 
[2,3]. IAV is classified into 16 HA and 9 NA subtypes, based on the antigenicity of two viral surface 
proteins—hemagglutinin (HA) and neuraminidase (NA). Almost all possible combinations of HA and 
NA  have been  isolated from aquatic birds, poultry, and other avian species. In humans and other 
mammals, limited subtypes of IAVs  have been detected  [4].  IAV  contains eight gene segments 
encoding the corresponding viral protein(s). Pandemic viruses are  generated by the rearrangement 
(reassortment) of viral RNA segments in cells infected with two different strains of IAV [5]. Thus, 
reassortment can theoretically result in 256 (2
8) different genotypes, and is a key source of pandemic 
viruses.  Avian and human IAVs  can  generally  infect  swine, and generate pandemic IAVs  by 
reassortment [5].  
Avian IAVs are differentiated on the pathogenicity in chickens between Highly pathogenic avian 
influenza  (HPAI)  and low pathogenic avian influenza (LPAI) viruses  [6,7].  In contrast to mild 
symptoms caused by LPAI viruses, HPAI viruses cause significant mortality in chickens. All HPAI 
virus reported belong to H5 or H7 subtypes, but only small amount of these subtypes are HPAI viruses. 
The HA0 cleavage site plays a critical role in the pathogenicity of avian IAVs [8,9]. Cleavage of HA 
precursor HA0 is required to fusion between host and viral membrane [10]. Thus, distribution of host 
protease that can cleave HA0  is critical for the  tropism  [9].  HA0  of LPAI virus is  cleaved by 
extracellular serine protease, meaning the spreading ability is limited to existence of available protease. 
On the other hand, that of HPAI virus are ubiquitously cleaved because the cleavage site contains 
multi-basic sequence (MBS), which is targeted by intracellular endoproteases, including PC6 and furin 
[8,9]. Thus, HPAI virus gains the ability to infect various cell types and cause systemic infections.  
HPAI H5N1  viruses were the cause of the first lethal human  infection  in Hong Kong in 1997 
[11,12,13]. This constituted the first definitive transmission of avian IAVs to humans, indicating that 
the HPAI H5N1 virus is able to infect humans directly, without prior reassortment in swine. The HPAI 
H5N1 virus in Hong Kong contained an HA  gene that was derived from A/goose/Guandong/1/96 
(H5N1; GS/GD/1/96-like virus); the remaining  seven segments were derived from A/teal/Hong 
Kong/W312/97 (H6N1; W312-like virus) [14,15]. The HA genes of HPAI H5N1 viruses belongs to 
GS/GD/1/96-linage and all HAs of HPAI H5N1 virus has a MBS (RRKKR) at the cleavage site [16]. 
During  2001 and 2002, the  HPAI H5N1 virus caused  avian outbreaks with frequent  reassortment 
[17,18].  In 2002,  genotype Z of eight new H5N1 genotypes generated by reassortment became 
dominant [19]. Since 2003, the HPAI H5N1 virus has spread via wild birds and poultry, throughout 
Asia to Europe and Africa, and has infected humans exposed to infected poultry [20,21,22]. The World Viruses 2012, 4                                       
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Health Organization (WHO) reported that the HPAI H5N1 virus has infected 592 individuals, causing 
349 deaths (~59% mortality) [23]. 
LPAI and HPAI H7 viruses cause several outbreaks among poultry, resulting in transmission of 
these viruses to humans [24]. Infection of LPAI and HPAI H7 viruses to humans usually result in 
conjunctivitis, which have rarely been reported with other subtypes including H5N1 HPAI viruses 
[25,26,27,28,29]. One of the largest outbreak of HPAI H7N7 virus occurred in the Netherland in 2003. 
About 90 confirmed human cases of HPAI H7N7 virus infection were reported. Most of these patients 
presented conjunctivitis, and some of them presented mild influenza-like illness. Only one patient, a 
57-year-old veterinarian, died as a result of pneumonia in combination with acute respiratory distress 
syndrome [26,27,29].The cleavage site of HPAI H7N7 virus contained MBS (KRRRR) [30].  
A recent pandemic of A/H1N1pdm occurred following reassortment between two swine IAVs—
triple-reassortant swine influenza virus and Eurasian-linage swine influenza virus [31]—indicating the 
possibility of the occurrence of an HPAI virus pandemic by similar reassortment. If this mutated HPAI 
virus were to acquire the ability for efficient human-to-human transmission with high pathogenicity of 
HPAI virus, it might pose a serious threat to human health and the global economy. To avoid this 
threat, there is a need for rapid diagnosis of IAVs (including avian IAVs), not only to allow early drug 
administration  for  improved  medical outcomes and patient care,  but  also  to  facilitate  effective 
containment of infected patients. In addition, surveillance of HPAI viruses in poultry and wild birds is 
required for outbreak management and preparation for pandemic.  
WHO and Office International des Epizooties  (World  Organisation for Animal Health; OIE) 
recommend  several  techniques, including enzyme-linked immunosorbent assay (ELISA), 
haemagglutination inhibition (HI) and neuraminidase inhibition (NI) tests, egg and tissue culture 
inoculation, agar gel immunodiffusion  (AGID) and both real-time and conventional reverse 
transcriptase PCR (RT-PCR) as newer molecular methods [32,33,34,35]. As a gold standard, IAVs 
have been categorized using the ELISA with HA and NA subtypes [36]. However, ELISA, HI and NI 
depend on specific antibodies and may not be suitable for identifying newly emerging strains. Viral 
replication in chicken eggs and/or tissue culture can generate a large amount of virus for diagnosis or 
subtyping. [33,37]. However, it requires 3~7 days to grow and the condition optimized for each viral 
strain.  AGID requires a large amount of antigen, meaning that the virus should be propagated in 
chicken eggs [32]. In contrast to the limitation of these classical methods, new technologies for the 
detection and characterization of viral RNAs and proteins have advanced dramatically in recent years. 
The new techniques offer surveillance and diagnosis advantages, such as rapidity, reliability, and cost-
effectiveness. 
2. Immunochromatography 
Immunochromatography  (IC), an antigen-based assay  completed within ~30 minutes, is an 
important rapid test for clinical diagnosis and surveillance of IAVs [38,39]. The principle is similar to 
that of  sandwich  ELISA.  The  nasal swab collected from patients  is  directly  mixed with viral  
antigen-specific antibody, conjugated with colloidal gold, colored latex, or a type of enzyme (Figure 1). 
The mixture is dropped onto a sample pad on a nitrocellulose membrane, containing immobilized viral 
antigen-specific antibody for capturing the  antigen. The antigen–antibody complex in the mixture Viruses 2012, 4                                       
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flows on the membrane, and contacts with the immobilized antibody, resulting in the appearance of a 
line or dot as a positive signal. 
IC is rapid and easy to use, but has a relatively low sensitivity [40,41]. The specificity is >90%, 
whereas the sensitivity is only ~60%. Thus, the technique is not suitable for the diagnosis of IAVs in 
the early stages of infection [41]. For detection of the H5 strain, the sensitivity of IC using H5-specific 
antibody  was reported to be 10
4.5–10
6  50 % egg infectious dose (EID50)/mL  [42].  Recently,  the 
sensitivity of IC has been improved by several new techniques. The simplest of these is to screen more 
specific and reactive antibodies. Miyagawa et al. [43] reported that the sensitivity of IC for the HPAI 
H5N1 virus  using  H5-specific antibodies was  10
3  TCID50/mL.  A  second  means of enhancing the 
sensitivity is to improve  the  detection system. For example, silver amplification is based on 
photographic technology, using silver halide crystals as a catalyst [44]. First, antigen and monoclonal 
antibody conjugated with gold nano particles are applied in the IC tip. Next, the buffer containing 
educing reagent and silver ions flows on the membrane. The silver ions cluster around the gold particle, 
such that the size of the colloidal gold particle is amplified ~100-fold as a silver cluster. The IC tip is 
then scanned by the specific IC reader and analyzed. The sensitivity of the method to detect HA 
protein of the HPAI H5N1 virus was reported to be 10 times higher than that of conventional  IC 
methods to detect NP protein of the HPAI H5N1 virus [44]. In other instance, improving the sensitivity 
of IC  is to conjugate the antibody  with fluorescent beads, Quantum dot,  or other fluorescent 
components  [45,46]. The IC strip is scanned by a  fluorescent reader and analyzed. Preliminary 
experiments indicate that the sensitivity of IC using fluorescent bead-conjugated antibody is 50 times 
higher than that of conventional IC methods using colloidal gold-conjugated antibody (unpublished 
data). Moreover, the fluorescent IC can be quantitatively analyzed. Silver amplification and fluorescent 
ICs  still take 30 minutes to detect IAVs and offer  advantages  over conventional  IC methods, but 
require specific scanners, including an  image analyzer and fluorescence reader.  Nevertheless, 
improved IC methods are expected to play an important role in the diagnosis and surveillance of IAVs, 
by offering rapidity and high specificity. 
 
Figure 1. Schematic diagram of immunochromatography. 
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3. Sample preparation for RNA detection systems. 
RNA detection systems, including PCR-based methods, DNA  amplification under isothermal 
conditions and DNA microarray, are required for sample preparation. Samples are collected from nasal 
swabs or throat lavage fluid of patients. Avian samples are collected from cloacal swabs or faeces. 
However, it is not limited to these samples. RNA extraction step is essential for molecular diagnoses 
detect RNA of IAV. The target RNA is extracted from these samples by using commercial RNA 
extraction kit, like QIAamp® viral RNA extraction kit (Qiagen, Hilden, Germany) using silica gel 
membrane technology. Crude sample such as faeces is not suitable for RNA extraction, because crude 
samples contain a mixture of component which could inhibit reaction of RNA detection. Dhumpa et. al. 
[47] developed a new purification system by using magnetic beads coated with monoclonal antibody 
against viral nucleoprotein, which interacts with viral RNA. This method can purified RNA for using 
RNA detection systems without RNA extraction step. RNA extraction is usually a significant time-
consuming step. Some protocols are available for automated system, like QIACube® (Qiagen, Hilden, 
Germany), which is suitable for a large amount of samples. Magnetic silica beads-based system is 
more rapid and convenient than spin column method with silica gel membrane technology, because 
high-speed centrifuge is dispensable [48,49,50]. Yang et. al. [51] reported a comparison of commercial 
systems for RNA extraction from DNA/RNA respiratory pathogens, indcluding IAV. KingFisher mL 
(ThermoFisher Scientific Inc., Worcester,  MA, USA)  and easyMAG  (bioMérieux,  Marcy l’Etoile, 
France) protocols using magnetic beads-based technology extracted 3- to 4-fold more RNA from the 
human IAV than other protocols. TruTip (Akonni Biosystems, Inc., Frederick, MD, USA) is a new 
RNA preparation system, based on a monolithic, porous nucleic acid binding matrix embedded within 
a pipette tip [52]. The technique is reported to be one of the most rapid RNA extraction methods 
(several minutes for 8 samples), and the RNA extraction efficiency and quality are comparable to 
QIAamp®  and  easyMAG  extraction system [52]. The development  of RNA extraction systems 
provides prospects for saving time in the PCR-based diagnoses. 
4. PCR-Based Methods 
4.1. Reverse Transcriptase-PCR/Degenerate Reverse Transcriptase-PCR 
RT-PCR is a classical technique for the rapid and accurate diagnosis and typing of RNA viruses, 
including IAVs [53]. For diagnosis of IAV, purified influenza A viral RNA is reverse transcribed into 
cDNA by a reverse transcriptase, and the cDNA is used for amplification with specific primers. In all 
eight segments of the IAV gene, the first 12 nucleotides of the 3′ terminus (Uni12) and the first 13 
nucleotides  of 5'  terminus (Uni13) are conservative. Thus,  the Uni12 and Uni13 sequences are 
amplified in a single step by all segments of IAV [54,55]. RT-PCR with Uni12 and Uni13 primers is a 
powerful tool for detecting IAV in human nasal swabs, and provides accurate information about viral 
subtypes by means of subsequent sequencing analysis.  
For subtyping of IAV, subtype-specific primers must be designed for amplification by RT-PCR, 
because of the variable sequences of HA and NA segments. Degenerated primers are suitable for the 
detection of unknown or newly emerging subtypes of IAV. Rapid identification of this cleavage site 
figures prominently in the surveillance of avian IAVs. PanHA RT-PCR is a new technique that uses Viruses 2012, 4                                       
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degenerated primers to amplify  the cleavage site of the  HA0  gene of variable subtypes  [56]. The 
degenerated primers contain five sets for amplifying the HA0 cleavage sites of all 16 HA subtypes. 
Direct sequencing of the PanHA RT-PCR products was accomplished for molecular characterization 
of the HA0 cleavage site sequences. Restriction fragment mass fingerprint (RFMF) analysis is a mass 
spectrometric diagnosis  for HA cleavage site  [57].  Amplified RT-PCR product containing HA 
cleavage site is digested with a dedicated restriction enzyme cocktail and the resulting fragments are 
analyzed by mass spectrometry. Subtyping of the NA genes of IAV has also been performed using 
degenerate RT-PCR  [58,59].  In this method, mixture degenerated primers  containing  the  M13 
sequence are used to amplify the fragments of all nine NA subtypes [58]. Although degenerate RT-
PCR is required for optimization of degenerated primers, the system utilized by degenerated primers is 
valuable for the first screening of unknown samples in surveillance. 
4.2. Quantitative Real-Time PCR 
Quantitative  real-time PCR (qRT-PCR) is frequently  used for detecting and subtyping viruses, 
including IAVs [60,61]. The method employs molecular oligonucleotide probes, conjugated with a 
fluorescent molecular or chemical dye for staining the  PCR products. One such example is the 
TaqMan® probe (Applied Biosystems, CA, USA), which is covalently conjugated with a fluorophore 
and  a  quencher at the  5′  and 3′  termini, respectively. This  results  in fluorescent quenching  and 
annealing  with  the specific region in the PCR products. The  PCR primers are extended by Taq 
polymerase, and the probe annealed with the PCR template is degraded by the 5′ to 3′ exonuclease 
activity of Taq polymerase. The degradation of the probe causes the separation of fluorophore from the 
quencher,  with the  fluorescence  detected in a PCR product dose-dependent manner.  The  SYBR® 
green method (Applied Biosystems, CA, USA) is a typical qRT-PCR protocol using an intercalator. 
SYBR green interacts strongly with double-stranded DNA, but only weakly with single-stranded DNA 
and RNA. The DNA–SYBR green complex expresses green fluorescent signals, and therefore the 
density of fluorescence is enhanced in proportion to the PCR product dose. Using oligonucleotide 
probes and intercalators, qRT-PCR  offers  high sensitivity, specificity,  and  a  wide range of 
quantification. Thus, it is one of the best techniques for the diagnosis and surveillance of IAVs. The 
TaqMan approach is commonly used in the diagnosis and surveillance of IAVs (including avian IAVs), 
because of its high sensitivity and specificity. The matrix gene segment of IAV, which is conservative 
in different subtypes, is a target of PCR amplification during detecting IAVs [62,63]. The sensitivity of 
the TaqMan method enables the detection of IAV in infected birds and humans. By contrast, in the 
SYBR green method, the reaction conditions must be optimized because of the absence of a specific 
probe. Nevertheless, this  lack of necessity for a  specific probe offers  a  simple and inexpensive 
approach for the diagnosis and screening of IAVs. Moreover, melting curve analysis of the SYBR 
green  method can be used to distinguish subtypes of IAV, and also  minor sequence variations  of 
different matrix genes [64,65]. Thus, the SYBR green method is more suitable for high-throughput 
diagnosis and surveillance than is the TaqMan approach. 
Recently, the TaqMan qRT-PCR method was applied specifically to detect HA and NA genes of the 
HPAI H5N1 virus. Using the optimized qRT-PCR system, HPAI H5N1 viral RNA was detected and 
quantified  in infected wild birds and humans  [66,67].  The sensitivity of the  TaqMan method for Viruses 2012, 4                                       
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detecting AI virus is extremely high. Using a specific TaqMan probe conjugated with minor groove 
binder groups, the minimum detectable level of viral genome was reported to be 0.001 TCID50/reaction 
and 0.08 EID50/reaction [68]. Locked nucleic acid (LNA), a high-affinity DNA analog, is suitable for 
improving the TaqMan probe, because the DNA/LNA copolymers are thermally stable and resistant to 
exo- and endonucleases [69,70]. qRT-PCR using a LNA-TaqMan probe was developed to detect two 
different clades (clade 1 and clade  2) of the  HPAI H5N1 virus from infected humans  [71].  The 
analytical sensitivity was 10–100 copies/reaction, and the sensitivity was 97% (56 H5N1 HPAI viruses 
were identified in 58 clinical samples of H5N1 HPAI virus.). Following intranasal inoculation, the 
HPAI H5N1 virus was detected in chicken meat, including cardiac and skeletal muscle [72]. SYBR-
green-based qRT-PCR was also reported to subtype all HA  and  NA  genes of avian IAVs  [73]. 
Hoffmann et al. [74] developed qRT-PCR with specific probes for HA cleavage site. The probe FliH5-
CS-FAM was designed to identify HA cleavage site of HPAI H5N1 virus Qinghai lineage and the 
qRT-PCR detected HPAI Qinghai-like viruses or very closely related isolates of Asian origin. These 
results indicate the importance of qRT-PCR in the clinical investigation and surveillance of the HPAI 
H5N1 virus.  
Figure 2. Schematic diagram of qRT-PCR. 
 
 
qRT-PCR offers high sensitivity and selectivity, but generally requires approximately 2 h per run, 
which is longer than the time required for rapid diagnosis systems such as IC. Super high-speed qRT-
PCR (SHRT-PCR) is a recently developed version of qRT-PCR, characterized by an extremely short 
reaction time (less than 20 min per run for 40 cycles) [75]. The reaction mixtures of qRT-PCR are 
applied to thin compact disc (CD)-type sample containers, sealed, and rotated on heat blocks at three 
different temperatures (Figure 3). The unique structural and thermodynamic properties of heat blocks 
fixed at three different temperatures are critical for the super high-speed polymerase chain reaction, 
because the blocks allow rapid temperature changes within the samples. The  SHRT-PCR system 
detects viral RNA segments of IAV, including the H5N1 subtype, as efficiently as conventional RT-
PCR methods, and therefore offers considerable advantages in the rapid diagnosis and detection of 
infections. Despite these advantages, the SHRT-PCR system is limited to a sample capacity of 12. Viruses 2012, 4                                       
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Given that a quantitative assay requires multiple defined amounts of sample to generate a standard 
curve, SHRT-PCR may be more suited to performing qualitative rather than quantitative assays. Thus, 
the system represents a  useful  alternative to  IC,  for  rapid diagnosis in local clinics  aimed at 
containment of infected patients. Nevertheless, the improved reaction speed of SHRT-PCR is expected 
to lay the foundation for a “new generation” qRT-PCR approach in the future. 
Figure 3. Schematic diagram of SHRT-PCR. 
 
Multiplex PCR is another variant of  RT-PCR or qRT-PCR,  characterized by multiple DNA 
amplification, with multiple sets of primers, in a single tube. The system has the advantage of high-
throughput typing and subtyping during the  surveillance of IAVs.  Multiplex RT-PCR  [76,77]  and 
multiplex qRT-PCR [78,79,80,81] have been extensively used for detecting avian IAVs, including the 
HPAI H5N1 virus. Suwannakarn et al. [82] developed multiplex qRT-PCR with TaqMan probes for 
typing and subtyping IAVs. Wang et al. [83] used multiplex qRT-PCR with SYBR green for subtyping 
of H5 subtypes, based on cost-effectiveness. FluPlex is a multiplex RT-PCR enzyme hybridization 
assay [84], reported to be capable of typing influenza viruses and subtyping HA (H1, H2, H3, H5, H7, 
and H9) and NA (human N1, animal N1, N2, and N7) proteins. Thus, almost all subtypes of IAVs 
isolated from humans are covered by multiplex PCR. The system exhibits high sensitivity (10–100 
copies/reaction),  and therefore plays  an important role in typing and subtyping aimed at  high-
throughput and high-sensitivity surveillance. 
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5. DNA Amplification under Isothermal Conditions 
5.1. Loop-Mediated Isothermal Amplification 
Loop-mediated isothermal amplification (LAMP) is similar to the  PCR-based method,  but  uses 
DNA amplification under isothermal conditions [85]. The system employs a DNA polymerase and 
four primers, including two “looping primers” and two “stripping primers”. First, the looping primers 
anneal on the F2 or B2 regions, and complementary DNA chains are amplified (Figure 4, step 2). Next, 
the stripping primers anneal on the F3 or B3 regions, and complementary DNA chains are amplified. 
This leads to the release of the complementary DNA chains generated by the looping primers (Figure 4, 
step 3). Finally, the single chain containing both terminals makes stem-loops (Figure 4, step 4). In the 
5′ terminal, the double-stranded F1 or B1 region works as a primer, resulting in the generation of a 
double-stranded chain containing a stem-loop (Figure 4, step 5). The stem-loop area (F2 or B2 region) 
is a single-stranded chain, and therefore new looping primers can anneal on the F2 or B2 region. A 
new complementary chain  is generated from the looping primer  (Figure  4,  step  6),  and strips  the 
corresponding chain (Figure 4, step 7 and 8). Similar to step 4, the 5′ terminal makes a stem-loop, and 
the new chains are generated (Figure 4, step 9). The extensions from the F2 or B2 region, and the 
extension formed by the looping primer on the stem-loop area, occur alternately (Figure 4, steps 9 and 
10). Finally, the long reaction products  containing tandem target sequence repeats are  generated 
(Figure 4, step 11).  
 
Figure 4. Schematic diagram of Loop-mediated isothermal amplification (LAMP). 
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Reverse transcription LAMP (RT-LAMP)  is an improved LAMP  suitable  for RNA detection. 
Reverse transcriptase (RTase) is added for reverse transcription performed by using looping primers or 
stripping primers. RT-LAMP has been used to detect the HPAI H5N1 virus [86,87], and other IAV 
subtypes  [88,89,90].  RT-LAMP  was comparable to that of the RT-PCR method currently 
recommended by WHO [87]. For detection of the avian IAV H9 subtype, the sensitivity of RT-LAMP 
was 10-fold higher than that of RT-PCR [90]. In the other hand, two commercial RT-LAMPs showed a 
lower sensitivity to detect several HPAI H5 and H7 viruses, including Southeast Asian HPAIV strains, 
than qRT-PCR [91]. This report indicates difficulty in optimizing LAMP primers with broad reactivity 
and specificity. RT-LAMP has also been used to identify IAV H1 and H3 subtypes, and to detect 
influenza B virus [86]. Nagatani et al. [92] monitored the amplified DNA by RT-LAMP, using a small 
and convenient portable potentiostat, with methylene blue as an intercalator. Although optimization of 
primer design is required for high sensitivity and specificity, the simplicity of LAMP makes it suitable 
for field surveillance and diagnosis in developing countries. 
5.2.  Nucleic  Acid  Sequencing-Based  Amplification/Real-Time Nucleic Acid  Sequencing-Based 
Amplification 
Nucleic acid sequencing-based amplification (NASBA) is an isothermal nucleic acid amplification 
system,  based on  transcription and reverse transcription [93]. The method utilizes RTase, RNA 
polymerase, RNaseH, a primer containing T7 promoter (primer 1), and a reverse primer (primer 2). 
First, primer 1 anneals with target sense RNA, and RTase extends the complementary DNA (Figure 5, 
steps 1 and 2). RNaseH recognizes the DNA–RNA hybrids, and only digests the RNA chain (Figure 5, 
step 3). RTase uses its DNA polymerase activity to generate double-stranded DNA with primer 2 
(Figure 5, step 4). The interaction of T7 RNA polymerase with T7 promoter on the double-stranded 
DNA generates antisense RNA (Figure 5, step 5). Using this antisense RNA as a template, RTase 
generates a DNA chain (Figure 5, step 6). RNaseH digests the RNA (Figure 5, step 7), and RTase 
generates double-stranded DNA (Figure 5, step 8). Finally, considerable quantities of antisense RNA 
are generated as reaction products (Figure 5, step 9).  
Figure 5. Schematic diagram of nucleic acid sequencing-based amplification (NASBA). 
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Figure 5. cont. 
 
 
 
NASBA is suitable for the detection of RNA viruses such as IAVs, because RNAs are utilized as 
amplification templates. The technique has been used to detect the HA gene of AI virus subtypes H5 
[94,95] and H7 [96], and also the matrix gene  [97], which is the consensus of all IAV subtypes.  
Real-time NASBA is a variant of NASBA, characterized by the use of a fluorescent-labeled probe or 
intercalator, and allowing a quantitative measurement. The limit of analytical detection of real-time 
NASBA for detecting  an  HPAI H5N1 virus  isolated from animals  was reported to be ≥10 
copies/reaction. By contrast, while TaqMan assay appeared to be less sensitive at approximately 100 
copies/reaction) [98]. In clinical samples obtained from seven confirmed human cases of HPAI H5N1 
virus  infection,  the level of sensitivity of NASBA was 10 TCID50/mL  [99].  Recently, real-time 
NASBA was used for the detection of IAV H1N1 and H3N2 subtypes, influenza B virus, respiratory 
syncytial virus (RSV), and metapneumovirus isolated from the swabs of patients with respiratory tract 
infections [100]. Multiplex NASBA is an improved method, which is suitable for the simultaneous 
quantification of multiple target genes  [101].  Multiplex NASBA with an enzyme-linked 
oligonucleotide capture optical detection method can distinguish between a group of viruses causing 
common lower respiratory tract infections, including influenza A and B viruses, human parainfluenza 
virus 1-4,  RSV, rubella virus,  and Coxsackie virus  [102].  The  high sensitivity and specificity  of 
NASBA makes it one of the most powerful tools for detection, surveillance typing and subtyping, 
laboratory research, and clinical investigation. Furthermore, similar to LAMP, the technique does not 
require expensive instruments such as thermal cyclers and fluorescent detectors. As such, isothermal 
detection systems are expected to play an important role in field surveillance and  diagnosis in 
developing countries. 
6. DNA Microarray 
DNA microarray is a collection of oligonucleotide, probes, or DNA spots immobilized on a solid 
surface. The technology  is applied to high-throughput and simultaneous  wide genomic screening 
[103,104].  DNA microarray also plays a critical role in medical diagnosis and surveillance of 
infectious diseases,  including  IAV  [105,106,107].  FluChip-55 is a  microarray  used  for typing and 
subtyping  IAVs. FluChip-55  recognizes  55 influenza viral sequences,  including  the  HA genes of Viruses 2012, 4                                       
 
 
1246 
subtypes H1, H3, and H5, and type B; the NA genes of subtypes N1 and N2; the M genes of types A 
and B; and the NP gene of type B [108,109]. Huang et al [110] developed a microarray simultaneously 
to type influenza A and B viruses, and to distinguish between subtypes H1N1 and H3N2 of the AI 
H5N1 virus. Recently, a universal oligonucleotide microarray for near-complete subtyping of IAVs 
was reported [107]. The microarray contains two sets of oligonucleotide probes, for classification of 
the subtypes of hemagglutinin (H1–H13, H15, and H16) and neuraminidase (N1–N9). By contrast, 
MChip is an unique microarray for typing and subtyping, characterized by identification of only the M 
gene segment of IAV  [111,112].  MChip utilizes only 15 short oligonucleotides for hybridization. 
Several target sequences were chosen to distinguish  between the different subtypes of IAV, while 
others were selected to identify a wide range of IAV subtypes. The pattern of fluorescence signal 
intensity of each array provides information on the IAV subtype. MChip was successfully employed in 
the identification of >100 AI H5N1 viruses and 16 historic H1N1 IAVs, including regenerated Spanish 
influenza virus A/Brevig Mission/1/1918 [112,113]. The use of DNA microarray is restricted, because 
of the requirement for expensive data collection instruments and specialized data analysis techniques. 
In addition, a microarray requires a certain amount of cDNA, which implies that the virus sample may 
have to be propagated in embryonated chicken eggs or culture cells. Nevertheless, the technique is one 
of the most powerful methods for detecting IAVs with extremely high-throughput. 
Figure 6. Schematic diagram of microarray. 
 
7. Concluding Remarks 
The frequent outbreaks of HPAI H5N1 viruses in the last decade have dramatically accelerated the 
development of diagnosis and surveillance methods. In 2009, this  process  was  highlighted  by the 
spread of  the first influenza  pandemic of the  21
st  century, caused  by swine-origin influenza virus Viruses 2012, 4                                       
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A/H1N1pdm, throughout Mexico and the southwestern USA. Global society is increasingly aware of 
the need for molecular diagnosis and surveillance of IAVs, in advance of newly emerging pandemics. 
A  wide variety  of methods for detecting HPAI H5N1 viruses have  been  developed  worldwide 
(Table.1).  
IC and improved IC (using silver amplification or fluorescent beads) can detect viral antigen within 
30 minutes without specific preparation. However, the easy and rapid diagnosis is less sensitive than 
other methods presented in the review (See chapter2). In addition, IC is based on antigen-based 
principle like ELISA, meaning IC could be low sensitivity for antigenic related emergent H5 or H7 
IAVs. Thus, IC is suitable for rapid check in small amount of samples or diagnosis in clinics and small 
hospitals.  Although  PCR-based methods are expected to be new gold standards, there are some 
advantages and disadvantages in each method. RNA extraction, which is usually a time consuming 
step, is one of disadvantages in these methods. However, the new technologies of RNA extraction 
systems provide prospects for saving time in the PCR-based diagnoses. (See chapter 3). Specificity 
versus sensitivity is a difficult problem, because high specific detection system would miss to detect 
new emerging virus. The primers and probes are designed in conservative regions yet mismatches with 
emerging sequences could occur. Although degenerate and multiplex PCR can detect a wide range of 
viral genome mutation, these primers easily cause non-specific amplification. Thus, the combination of 
initial screen using degenerate and multiplex PCR and specific diagnosis using qRT-PCR is preferable 
to detection of HPAI H5N1 and H7N7 viruses. PCR-based methods require approximately 2 hours for 
PCR. SHRT-PCR is characterized by an extremely short reaction time (less than 20 minutes). The 
combination of SHRT-PCR and TruTip (See chapter 3) is comparable to IC in amount of time required, 
however SHRT-PCR remains at laboratory stage because of the limited capacity of samples and 
immature usability. Although PCR-based methods can identify the subtypes of H5 and H7 viruses, a 
portion of H5N1 viruses and a certain level of H7N7 viruses are not HPAI but LPAI viruses. For 
detection of HPAI viruses, cleavage site of HA should be analyzed. Sequencing or mass spectrometric 
assay for amplified PCR product containing HA cleavage site is suitable for characterization of HA 
cleavage site (see chapter 4.1). However, these methods require the additional expensive installments. 
Although qRT-PCR with specific probes for HA cleavage site is capable of differentiation between 
HPAI and LPAI viruses, the high specificity could miss other linages of HPAI viruses (see chapter 4.2). 
RT-LAMP and NASBA show great potential for IAVs detection in developing countries and field 
surveillance, because isothermal instruments can be cheap and mobile. If these methods are used under 
such rough conditions, requirement of RNA extraction is a bigger problem than the case of PCR-based 
method.  Microarray is potentially  a  great  powerful  tool  for detecting IAVs  with extremely   
high-throughput, however the equipment is expensive and the analysis is complex. Thus, the system is 
suitable for high-level laboratory or national core facility. Although  some  of these techniques  are 
expected to become gold standards for the diagnosis of IVAs, many remain at the laboratory stage. 
Further optimizations and validations are required before such methods are suitable for clinical and 
surveillance applications.  Moreover, continuous upgrades in the  diagnosis of IAV  are  required, 
because of frequent reassortment. Nevertheless, the methods we reviewed can offer the best prospects 
for  providing critical information  useful for prevention  and  control of newly emerging 
pandemic viruses. 
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Table 1. Comparison of diagnosis methods for influenza A virus 
 
Improved IC:IC with silver amplification or fluorescent beads, RT-PCR: reverse transcription PCR, 
qRT-PCR: quantitative real-time PCR, SHRT-PCR: super high speed real-time PCR, RT-LAMP: 
reverse transcription Loop-mediated isothermal amplification, NASBA: Nucleic acid sequencing-
based amplification 
Acceptable specimens (not limited to): virus isolates; nasal, throat and cloacal swab; nasal bronchial 
and throat wash. 
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